Inventor · disambiguated record
Terence O'Reilly
Also filed as: O'REILLY TERENCE
10 granted patents·11 pending applications·124 citations·filing 1999–2013
89Inventor score
Top patents by PatentIndex Score
21 records- 0187US6302838B1Cancer treatment with epothilonesNOVARTIS AG·Filed 1999·Granted Oct 16, 2001·86 cites·24 claims
- 0283US8778962B2Treatment of solid tumors with rapamycin derivativesLANE HEIDI·Filed 2012·Granted Jul 15, 2014·4 cites·6 claims
- 0383US7875601B2Cancer treatment with epothilonesNOVARTIS AG·Filed 2006·Granted Jan 25, 2011·5 cites·36 claims
- 0483US7091226B2Cancer treatment with epothilonesNOVARTIS AG·Filed 2005·Granted Aug 15, 2006·2 cites·37 claims
- 0582US8410131B2Cancer treatmentLANE HEIDI·Filed 2002·Granted Apr 2, 2013·11 cites·9 claims
- 0681US6635666B2Cancer treatment with epothilonesNOVARTIS AG·Filed 2001·Granted Oct 21, 2003·13 cites·7 claims
- 0773US7749698B2p53 wild-type as biomarker for the treatment with mTOR inhibitors in combination with a cytotoxic agentNOVARTIS AG·Filed 2005·Granted Jul 6, 2010·1 cites·5 claims
- 0864US8877771B2Treatment of solid tumors with rapamycin derivativesLANE HEIDI·Filed 2013·Granted Nov 4, 2014·0 cites·22 claims
- 0963US2014105895A1Treatment of solid tumors with rapamycin derivativesLANE HEIDI·Filed 2013·Application pending·0 cites
- 1062US7723339B2Combination comprising a signal transduction inhibitor and an epothilone derivativeNOVARTIS AG·Filed 2002·Granted May 25, 2010·2 cites·10 claims
- 1161US8436010B2Treatment of solid tumors with rapamycin derivativesLANE HEIDI·Filed 2012·Granted May 7, 2013·0 cites·11 claims
- 1261US2013244951A1Treatment of solid tumors with rapamycin derivativesLANE HEIDI·Filed 2013·Application pending·0 cites
- 1361US2013253000A1Treatment of solid tumors with rapamycin derivativesLANE HEIDI·Filed 2013·Application pending·0 cites
- 1460US2009202541A1Combination comprising n-{5-[4-(4-methyl-piperazino-methyl)-benzoylamido]-2-methylphenyl)-4-(3-pyridyl)-2pyrimidine-amine and a chemotherapeutic agentBRUNS CHRISTIAN·Filed 2009·Application pending·0 cites
- 1560US2004024033A1Cancer treatment with epothilonesFiled 2003·Application pending·0 cites
- 1650US2012283206A1Combination comprising N--4-(3-pyridyl)-2pyrimidine-amine and a chemotherapeutic agent.BRUNS CHRISTIAN·Filed 2012·Application pending·0 cites
- 1747US2009012105A1Combination of Mtor Inhibitor and Antipolate CompoundNOVARTIS AG·Filed 2008·Application pending·0 cites
- 1847US2004167134A1Combination comprising n-{5-[4-(4-methyl-piperazino-methyl)-benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2pyrimidine-amine and a chemotherapeutic agentFiled 2002·Application pending·0 cites
- 1944US2007167478A1Biomarkers for sensitivity of proliferative diseases to mtor inhibitorsBOULAY ANNE·Filed 2004·Application pending·0 cites
- 2043US2008207565A1Use of bisphosphonates for pain treatmentFOX ALYSON·Filed 2008·Application pending·0 cites
- 2137US2004063670A1Use of bisphosphonates for pain treatmentFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Terence O'Reilly files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →